As shown in Table 3 and Figure 9, IDO1 expression in more than 10% of tumor cells was determined as the threshold for reaching significance levels for ER-α status and mitotic count between IDO1-positive and IDO1-negative tumors. This evidence concerns the gene IDO1 and neoplasm.